Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Share Price

Price 123.40p on 18-04-2025 at 04:45:12
Change 0.00p 0%
Buy 123.60p
Sell 123.00p
Buy / Sell PRTC Shares
Last Trade: Sell 50,137.00 at 123.40p
Day's Volume: 0
Last Close: 123.40p
Open: 0.00p
ISIN: GB00BY2Z0H74
Day's Range 0.00p - 0.00p
52wk Range: 100.40p - 238.50p
Market Capitalisation: £296m
VWAP: 0.00p
Shares in Issue: 240m

PureTech (PRTC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 50,137 123.40p Uncrossing Trade
16:35:27 - 17-Apr-25
Buy* 238 123.40p Automatic Execution
16:29:46 - 17-Apr-25
Buy* 311 123.40p Automatic Execution
16:29:46 - 17-Apr-25
Sell* 223 122.80p Automatic Execution
16:29:46 - 17-Apr-25
Sell* 251 122.80p Automatic Execution
16:29:46 - 17-Apr-25
Sell* 266 122.80p Automatic Execution
16:29:46 - 17-Apr-25
Sell* 7 123.00p Automatic Execution
16:29:46 - 17-Apr-25
Sell* 74 123.00p Automatic Execution
16:29:46 - 17-Apr-25
Buy* 718 123.40p Automatic Execution
16:28:35 - 17-Apr-25
Buy* 548 123.40p Automatic Execution
16:28:35 - 17-Apr-25
See more PureTech trades

PureTech (PRTC) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Apr 2025 (Thu) 123.80 125.60 121.20 123.40 301,063
16th Apr 2025 (Wed) 125.00 125.00 120.00 122.40 380,387
15th Apr 2025 (Tue) 120.40 127.20 120.40 124.40 276,235
14th Apr 2025 (Mon) 118.00 128.00 118.00 125.40 1,234,305
11th Apr 2025 (Fri) 105.00 118.00 105.00 118.00 1,662,455
10th Apr 2025 (Thu) 113.20 115.20 101.40 103.00 2,028,294
9th Apr 2025 (Wed) 115.00 116.00 100.40 103.00 3,022,995
8th Apr 2025 (Tue) 130.00 130.00 117.20 117.60 4,763,463
7th Apr 2025 (Mon) 125.00 138.20 119.00 138.20 1,745,375
4th Apr 2025 (Fri) 138.80 139.20 126.00 129.20 915,118
3rd Apr 2025 (Thu) 138.60 142.20 135.60 138.80 544,139
2nd Apr 2025 (Wed) 145.00 147.00 139.40 142.00 1,139,971
1st Apr 2025 (Tue) 142.60 147.80 140.60 147.00 636,773
31st Mar 2025 (Mon) 144.60 146.20 138.40 143.60 800,906
28th Mar 2025 (Fri) 130.80 147.60 130.80 146.40 1,435,145
27th Mar 2025 (Thu) 126.00 136.20 123.20 134.40 1,281,933
26th Mar 2025 (Wed) 128.00 128.20 126.60 127.20 277,296
25th Mar 2025 (Tue) 129.80 131.00 127.60 127.60 283,481
24th Mar 2025 (Mon) 129.00 131.40 128.20 131.00 186,057
21st Mar 2025 (Fri) 131.00 131.00 128.80 129.20 623,758
20th Mar 2025 (Thu) 134.00 134.80 129.00 131.40 678,320
19th Mar 2025 (Wed) 134.00 134.20 131.40 132.00 106,123
18th Mar 2025 (Tue) 135.00 135.00 130.00 134.00 292,800
See more PureTech price history

PureTech (PRTC) Share News

SMALL-CAP WINNERS & LOSERS: Helical celebrates "significant activity"

11th Apr 2025 10:52

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

TRADING UPDATES: PureTech Health confirms Nordic Capital bid interest

7th Apr 2025 21:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

PureTech receives FDA fast track designation for leukemia treatment

9th Jan 2025 12:26

(Alliance News) - PureTech Health PLC on Thursday said that the US Food & Drug Administration has granted fast track designation to its antibody LYT-200 for the treatment of acute myeloid leukemia. Read More

IN BRIEF: PureTech Health says LYT-100 slows lung function decline

16th Dec 2024 14:35

PureTech Health PLC - Boston, Massachusetts-based biotechnology company - Notes that deupirfenidone, also known as LYT-100, slows lung function decline in people with idiopathic pulmonary fibrosis as measured by forced vital capacity in a phase 2b trial. Toby Maher, professor of medicine & director of interstitial lung disease at Keck School of Medicine at the University of Southern California in Los Angeles, and lead investigator in the Elevate IPF trial, says: "Deupirfenidone has the potential to offer patients a highly effective and tolerable treatment option. These are extremely exciting results from a phase 2b trial, and I am very enthusiastic about the continued development of deupirfenidone." Read More

LONDON BRIEFING: Vodafone-Three deal green lit; Shell and Equinor team

5th Dec 2024 07:59

(Alliance News) - London's FTSE 100 is called to open slightly lower on Thursday, despite US stocks spiking to record highs overnight. Read More

See more PureTech news
FTSE 100 Latest
Value8,275.66
Change0.00

Login to your account

Forgot Password?

Not Registered